The switch from sulfonylurea to preprandial short-acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus. Diabetes Technol Ther 2006; 8: 375-384.Pfutzner A, Lorra B, Abdollahnia MR, Kann PH, Mathieu D, Pe...